Treatment and follow-up
The median follow-up period of the patients was 8 months (range: 1
month-5 years and 9 months). Thirty-three (50.8%) patients continued to
follow up in our clinic. Inhaled ipratropium bromide therapy was started
for 37 (56.9%) patients and terminated after 6 months in four patients
because of clinical improvement yet the others continued to treatment.
While 20 (30.8%) patients needed supplemental oxygen therapy after
diagnosis of malacia, 10 (15.4%) patients required continuous positive
pressure support with invasive MV. Only one patient needed non-invasive
MV treatment. Tracheostomy was performed in 10 (15.4%) patients who
were underwent invasive MV treatment; of them, two had isolated TM and
one had TBM. None of the patients was performed any surgical treatment
for malacic airways. Three patients (4.6%) died during follow-up.